Comprehensive gene analysis including next generation sequencing (NGS) study with immunological parameters to obtain the biomarkers for immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC)

e20040Background: ICIs have been widely developing in the field of NSCLC. Several kinds of biomarkers predicting the efficacy of ICIs, such as PD-L1 expression, frequency of tumor infiltrating lymp...